Find a Commonwealth Resource
Ripretinib
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Qinlock (ripretinib) is an oral prescription tablet that acts as a kinase inhibitor, targeting enzymes like KIT and PDGFR alpha to help manage certain cancers. Manufactured by Deciphera Pharmaceuticals, LLC, it comes in 50 mg doses. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Ripretinib
Access the FDA dataset for Ripretinib — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025